AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (3.4 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Rapid Communication | Open Access

Immune patterns of the tumor microenvironment in PD-L1+ EGFR+ HNSCC patients received anti-PD-1 and EGFR-based neoadjuvant therapy

Yuan Zhia,b,cWenhao Rena,bShaoming Lia,bJingjing Zhenga,bJianzhong SongdLing Gaoa,bKeqian Zhia,b( )
Department of Oral and Maxillofacial Reconstruction, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266555, China
Key Lab of Oral Clinical Medicine, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266555, China
Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology, Beijing 100083, China
Department of Oral and Maxillofacial Surgery, People's Hospital of Rizhao, Rizhao, Shandong 276827, China

Peer review under the responsibility of Chongqing Medical University.

Show Author Information

References

【1】
【1】
 
 
Genes & Diseases

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhi Y, Ren W, Li S, et al. Immune patterns of the tumor microenvironment in PD-L1+ EGFR+ HNSCC patients received anti-PD-1 and EGFR-based neoadjuvant therapy. Genes & Diseases, 2026, 13(4). https://doi.org/10.1016/j.gendis.2025.101902

3

Views

0

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 07 January 2025
Published: 24 October 2025
© 2025 The Authors.

This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).